Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death.
about
Autophagy signal transduction by ATG proteins: from hierarchies to networksTargeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implicationsAutophagy in cellular metabolism and cancerYou eat what you are: autophagy inhibition as a therapeutic strategy in leukemiaAutophagy gene expression profiling identifies a defective microtubule-associated protein light chain 3A mutant in cancerPhase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma.Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy.Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights.Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia.Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with TemozolomideHistone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer.A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosisFoxk proteins repress the initiation of starvation-induced atrophy and autophagy programs.Coibamide A induces mTOR-independent autophagy and cell death in human glioblastoma cells.Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinicSuberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, enhances radiosensitivity and suppresses lung metastasis in breast cancer in vitro and in vivo.Autophagy induction by histone deacetylase inhibitors inhibits HIV type 1.Pharmacologic agents targeting autophagy.The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma CellsHDAC Family Members Intertwined in the Regulation of Autophagy: A Druggable Vulnerability in Aggressive Tumor Entities.Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways.Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer.Silvestrol induces early autophagy and apoptosis in human melanoma cellsInhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.Unfolded protein response to autophagy as a promising druggable target for anticancer therapy.Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin-proteasomal and autophagy systems.Acetylated hsp70 and KAP1-mediated Vps34 SUMOylation is required for autophagosome creation in autophagy.Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse modelSuperior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer.Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagyHistone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagySuperior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLCTriggering autophagic cell death with a di-manganese(II) developmental therapeuticSelenium compounds, apoptosis and other types of cell death: an overview for cancer therapy.The ULK1 complex: sensing nutrient signals for autophagy activation.Targeting autophagy to enhance oncolytic virus-based cancer therapy.Role of anoctamins in cancer and apoptosis.Autophagy and transporter-based multi-drug resistance.Histone deacetylase inhibitors and cell death.Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.
P2860
Q26782670-91168983-F79B-44B2-A13D-8007025C760CQ26853394-74131F1B-FA8F-452C-8301-112D357D7B18Q26996211-8E248287-8A1E-4CF9-9AA8-6514ABFFE9E9Q26998971-B1924D90-6BFA-446A-A541-57518C3641BEQ28396865-3AC87D42-E5E7-46EA-8A8B-1E07FE3C7B09Q33410761-F7F4F36B-0EA8-4B2B-BD75-1652DD66712CQ33839054-4B44425E-1310-4F97-9B96-A34038CDD869Q33983255-33BC9014-EA14-4980-9D51-7E5C1936E4D8Q34038766-DE194BDA-CC35-413D-8904-5BDDFDEDFA8FQ34318242-F370F177-A854-4E66-8822-966D231C0D3AQ34346813-5A07AC4A-C5C3-4449-8F0E-515EBDC6197AQ34398390-7904A9D3-E8D6-4CEA-8E73-6738A497887CQ34603552-68BB4FA1-DAD8-45CD-9556-3CB3D0B932EDQ34769744-5024E378-44E9-4D84-9B99-C02DDD7CB521Q34817365-95AF54AF-8BB7-418F-AF5A-6D29C985889CQ35018496-63EC56AF-A332-49C1-8EF6-D896677F5C17Q35103991-B72F0711-C8FE-47E1-A755-289EC2D578D3Q35242546-F127247E-93DB-4D2B-A8D9-EE083696F201Q35636540-54152F19-48F1-4784-8FC1-3473DC486D72Q35824343-DA128D4A-4C01-4261-BB78-D699C3BE996DQ35852901-7FB0371D-2B55-4928-A7F3-BAB391E77E50Q35876617-D562F9E3-FEE9-4DE3-B1B4-E33819E30CD9Q35893093-C69B8D4B-FE23-41B2-B5D4-7F5B4781B6B7Q36086324-A088DCAB-4D60-4308-9432-AE4D248E0764Q36403652-36A7E516-3D0D-4E67-9DA8-6AE88C50D5DCQ36435854-BE5AEA57-628E-4A67-8187-B215106E3958Q36799136-D594177A-D84D-4FFA-8D22-DB457FF740BBQ36994540-99467387-F309-4B7C-B842-35C50B918772Q37030911-AC9F8BE5-C0C0-4F96-A9E6-7B2C5ACC5EF9Q37626910-6946D30F-6B53-45E5-892B-1BF5060D2C90Q37644099-D307666B-A1DB-43CC-A353-A746B0AD5052Q37645002-004C37F3-754A-4F09-89A8-EF1E71EAB10EQ37670137-9A82B1C5-193E-4547-AB29-9640857C4991Q38040788-97C5C8A1-1E0F-42D3-A7ED-447A91698D96Q38072216-B573493B-09EE-4BBE-AA45-C7F29B800D31Q38089106-779EE8DB-F6F7-47CA-8FE9-24AF9EE0D0C1Q38184980-040ED7D6-F87B-41D2-8CEF-F40A03163870Q38202874-418D0903-3D5E-431D-869F-4E0E9CDFD2E4Q38217666-FAEBCB42-D40C-4414-89F7-14A606739797Q38240733-B1F93A0C-4F65-4F6D-887B-39AF0B267BF3
P2860
Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Role of autophagy in histone d ...... c and nonapoptotic cell death.
@ast
Role of autophagy in histone d ...... c and nonapoptotic cell death.
@en
type
label
Role of autophagy in histone d ...... c and nonapoptotic cell death.
@ast
Role of autophagy in histone d ...... c and nonapoptotic cell death.
@en
prefLabel
Role of autophagy in histone d ...... c and nonapoptotic cell death.
@ast
Role of autophagy in histone d ...... c and nonapoptotic cell death.
@en
P2093
P2860
P356
P1476
Role of autophagy in histone d ...... c and nonapoptotic cell death.
@en
P2093
Cindy Puente
Noor Gammoh
Paul A Marks
Xuejun Jiang
P2860
P304
P356
10.1073/PNAS.1204429109
P407
P577
2012-04-09T00:00:00Z